/
/
/

Nath Bio-Genes (India) Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
₹328 Cr₹52 Cr₹66 Cr₹44 Cr₹284 Cr₹52 Cr₹37 Cr₹32 Cr₹244 Cr₹43 Cr₹32 Cr₹23 Cr₹235 Cr₹45 Cr₹25 Cr₹22 Cr₹209 Cr₹27 Cr
₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹48 L₹8 L₹13 L₹41 L₹4 L₹6 L₹12 L₹26 L₹6 L₹20 L₹4 L₹73 L
₹330 Cr₹54 Cr₹68 Cr₹46 Cr₹285 Cr₹56 Cr₹37 Cr₹32 Cr₹244 Cr₹43 Cr₹32 Cr₹23 Cr₹235 Cr₹45 Cr₹25 Cr₹22 Cr₹209 Cr₹28 Cr
₹294 Cr₹48 Cr₹63 Cr₹39 Cr₹255 Cr₹53 Cr₹30 Cr₹28 Cr₹208 Cr₹40 Cr₹27 Cr₹18 Cr₹199 Cr₹42 Cr₹20 Cr₹18 Cr₹176 Cr₹50 Cr
₹37 Cr₹7 Cr₹5 Cr₹8 Cr₹31 Cr₹4 Cr₹9 Cr₹5 Cr₹37 Cr₹4 Cr₹6 Cr₹5 Cr₹37 Cr₹4 Cr₹6 Cr₹5 Cr₹34 Cr-₹21 Cr
₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹3 Cr₹1 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr
₹33 Cr₹2 Cr₹2 Cr₹3 Cr₹29 Cr₹2 Cr₹4 Cr₹1 Cr₹34 Cr₹2 Cr₹5 Cr₹2 Cr₹33 Cr₹2 Cr₹2 Cr₹2 Cr₹31 Cr-₹113 Cr
₹32 Cr-₹90,000₹2 Cr₹3 Cr₹28 Cr₹1 Cr₹3 Cr₹1 Cr₹33 Cr₹3 Cr₹4 Cr₹2 Cr₹33 Cr₹1 Cr₹1 Cr₹1 Cr₹31 Cr-₹116 Cr

Share Price Live Stats

Open (₹)154.00
Volume (₹)5,349.00
High (₹)154.94
Upper Circuit183.68
Low (₹)151.66
Lower Circuit122.46
Prev Close153.07
52W High (₹)204.00
Price153.00
52W Low (₹)126.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)292.57 Cr
Div. Yield (%)1.30
PE Ratio7.99
Debt to Equity0.19
Price to Book0.43
Book Value339.08
EPS (TTM)19.26
Face Value10.00
ROE (%)6.15

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
KSCLNSE
VENKEYSNSE
AVTNPLNSE
FRESHARA-STNSE
BSHSLNSE
REGAALNSE
MGEL-BENSE
SHEETAL-SMNSE
KOTYARK-BENSE
NATHBIOGENNSE
LTP
1W Low
1W High
Market cap (₹)
750.85-35.95 (-4.57%)
735.95
790
3,837Cr
1666.5+94.6 (6.02%)
1575.40
1747.40
2,362Cr
91.42+6.23 (7.31%)
84.60
97
1,394Cr
422-16.9 (-3.85%)
417.80
477.95
1,033Cr
92+0.15 (0.16%)
88.10
93
931Cr
90.04-2.47 (-2.67%)
85.45
94.47
919Cr
14.26-0.19 (-1.31%)
13.90
14.75
477Cr
348.1+8.3 (2.44%)
332
352
408Cr
33.76-1.04 (-2.99%)
30.05
34.34
364Cr
153-4.3 (-2.73%)
151.66
160.39
293Cr

Key Highlights of Nath Bio-Genes (India) Ltd’s P&L

In 2025-03-31, Nath Bio-Genes (India) Ltd reported total revenue of ₹369.45Cr, compared with ₹333.25Cr in 2024-03-31, reflecting Nath Bio-Genes (India) Ltd turnover.

Depreciation was ₹3.82Cr and finance costs were ₹10.65Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹40.58Cr in 2025-03-31 as compared to ₹41.56Cr in 2024-03-31.

Net Profit (PAT) was ₹38.6Cr in 2025-03-31 compared with ₹39.62Cr in 2024-03-31.

Earnings per share (EPS) were ₹20.31 in 2025-03-31, compared with ₹20.85 in 2024-03-31.